Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid

Arthritis and Rheumatology

Volumn 67, Issue 10, 2015, Pages 2673-2678

  Leijten, Emmerik F A ^a   van Kempen, Tessa S ^a   Boes, Marianne ^a   Amelsfort, Jocea M R Michels Van ^a   Hijnen, Dirkjan ^a   Hartgring, Sarita A Y ^a   van Roon, Joel A G ^a   Wenink, Mark H ^a   Radstake, Timothy R D J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CCR6 PROTEIN, HUMAN; CD146 ANTIGEN; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; MCAM PROTEIN, HUMAN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2 PROTEIN, HUMAN;

ADULT; CASE CONTROL STUDY; CYTOLOGY; HUMAN; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; ANTIGENS, CD146; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; LYMPHOCYTES; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; RECEPTORS, CCR6; SYNOVIAL FLUID;

EID: 84948711879     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/ART.39261     Document Type: Article

References (17)

1. Hazenberg MD, Spits H. Human innate lymphoid cells. Blood 2014;124:700–9.
2. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 2013;13:145–9.
3. Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011;208:1127–33.
4. Teunissen MB, Munneke JM, Bernink JH, Spuls PI, Res PC, Te Velde A, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(1) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014;134:2351–60.
5. Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp441 ILC3 in psoriasis. The J Invest Dermatol 2014;134:984–91.
6. Dyring-Andersen B, Geisler C, Agerbeck C, Lauritsen JP, Gudjonsdottir SD, Skov L, et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 2014;170:609–16.
7. Basu R, O’Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012;37: 1061–75.
8. Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, et al. Rorgammat1 innate lymphocytes and gD T cells initiate psoriasiform plaque formation in mice. J Clin Invest 2012;122: 2252–6.
9. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1b reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 2010;107:10961–6.
10. Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013;14:221–9.
11. Ciccia F, Guggino G, Rizzo A, Saieva L, Peralta S, Giardina A, et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis 2015. E-pub ahead of print.
12. Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, et al. Human RORgt(1)CD34(1) cells are lineagespecified progenitors of group 3 RORgt(1) innate lymphoid cells. Immunity 2014;41:988–1000.
13. Mizuno S, Mikami Y, Kamada N, Handa T, Hayashi A, Sato T, et al. Cross-talk between RORgt1 innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn’s disease. Inflamm Bowel Dis 2014;20:1426–34.
14. Robinette ML, Fuchs A, Cortez VS, Lee JS, Wang Y, Durum SK, et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol 2015;16:306–17.
15. Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, et al. RORgt(1) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013;38:1223–35.
16. Bialoszewska A, Baychelier F, Niderla-Bielinska J, Czop A, Debre P, Vieillard V, et al. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes. Cell Immunol 2013;285:6–9.
17. Nielsen N, Pascal V, Fasth AE, Sundstrom Y, Galsgaard ED, Ahern D, et al. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunol 2014;142:581–93.